- Rising Health Costs Push Some Middle-Aged Adults To Skip the Doc Until Medicare
- Even With Dental Insurance, You Still Could Face a Large Bill
- Don't Forget This: Study Shows Cannabis Exacts a Toll on Your Memory
- Want To Stress Less? Start With These Everyday Habits
- Journalists Shine Light on Out-of-Reach Insurance Prices, AI’s Role in Claims Disputes, and Susie Wiles
- Arizona behavioral health center adds 10 adolescent beds
- The explosion of the Medicare Advantage special needs plan
- The explosion of the Medicare Advantage special needs plan
- We’re Great Thinkers…But Not Rethinkers
- North Star to cut additional jobs
- North Star to cut additional jobs
- Oregon Governor asks PeaceHealth to delay contract switch: 11 things to know
- 6 Optum updates to know from Q1
- Viewpoint: US nursing workforce faces several risks
- The shifting dental hygiene landscape
- 12 dental insurance updates in 30 days
- ‘The 1980s called’: CMS to phase out fax, mail
- ‘The 1980s called’: CMS to phase out fax, mail
- Aligning IT & clinical teams: How to reduce friction and improve communication
- AI tool targets billing gaps at Kentucky system
- AI in pharmacy: Why pilots stall at hospitals
- 37 recent hospital, health system executive moves
- This ASC startup is wiring AI into the fabric of outpatient surgery
- Springer Nature retracts 38 papers over autism dataset
- Intermountain plans new outpatient clinic
- Legacy Health, Regence BCBS face looming contract expiration
- Meet the COOs of the largest DSOs
- Michigan bills target outpatient fees, CON requirements
- Anesthesia group, lawmakers oppose Medicare cuts to non-opioid pain treatment
- Iowa lifts emergency suspension of transplant surgeon’s license
- Vascular center, physician CEO to pay $4M to settle fraud allegations
- In the Affordability Alphabet Soup of the ACA and EHBs, a Link to Higher Premiums Isn’t Clear-Cut
- 5 cardiologists stepping into leadership roles
- New York organizations partner on intellectual, developmental disabilities campus
- Cincinnati hospital acquires outpatient center for $6M
- CMS final rule aims to axe the fax machine, phase out paper mailing
- 24 profitable health systems in 2025
- How 2 CFOs plan for uncertainty
- Heartland Dental expands with Texas affiliation
- MD Anderson opens colorectal cancer center
- SALT Dental Partners adds Washington practice
- 11 dental school updates to know
- 6 health systems seeking revenue cycle executive directors
- Remarks at The SEC Speaks in 2026: From Kitchen Table to Cap Table—Making Capital Formation Work for Small Businesses
- Integrated care model drives 76% depression improvement in 44 days: Study
- Heart Benefits From GLP-1 Drugs Fade After Stopping, Study Finds
- Survey Shows More People Struggling To Afford ACA Insurance
- Up to 155,000 COVID Deaths May Not Have Been Counted, Study Finds
- FDA Drops Plan To Ban Tanning Beds for Minors Nationwide
- Idaho bill proposes consolidating dental regulatory oversight
- Washington hospital charts path to preserve primary care
- 4 DSOs making headlines
- 6 state behavioral health policy updates
- 80% of returning ACA enrollees report higher healthcare costs in 2026
- Fitch downgrades HonorHealth’s credit rating
- NYC Health + Hospitals names dentistry, oral surgery leaders
- Mindray North America Enters Ventilator Market
- Mindray North America Enters Ventilator Market
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- LivaNova Receives FDA Premarket Approval for to treat Moderate to Severe Obstructive Sleep Apnea
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- Perfuze Receives FDA 510(k) Clearance for Millipede88 Aspiration Catheter
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- EPA proposes new rule on Ethylene Oxide Emissions: Could Loosen Limits on Medical Device Sterilization
- With Novo's semaglutide going off patent, Indian drugmakers set to launch their cheaper generics
- Sanofi backs 2 more documentary films about rare blood disorders
- ACIP member's miscommunication on vaccine panel's future adds to confusion after court ruling
- Rhythm's Imcivree scores 'transformative' FDA approval in brain damage-related obesity
- Some Patients With ADHD and Addiction History Missing Out
- Social Media Poses Risks to Children's Mental Health, Review Concludes
- 'Early Bird' Exercisers Get The Most Health Benefits, Study Finds
- Does Closing Your Eyes Help You Hear Better?
- High Blood Pressure Deaths Quadruple Among Young Women, Study Finds
- Meningitis Vaccine Doesn't Protect Gay, Bisexual Men From Gonorrhea, Clinical Trial Concludes
- Oz Escalates Medicaid Fraud Claims Against States After Focus on Minnesota
- Listen: Trump’s NIH ‘Reset’ Is Driving Away Scientists
- ‘How Low Can You Go?’ The Shifting Guidelines for Blood Pressure Control
- Mississippi to fund clinical trials for psychedelic drug
- Lawmakers push bill to boost mental health workforce, diversity
- Florida State partners with behavioral health provider on research
- Utah governor signs hygienist autonomy bill
- UHS CEO: Talkspace deal builds 1st national ‘end-to-end’ behavioral model
- Psychedelic therapy shows no benefit over antidepressants: Study
- What the Health? From KFF Health News: RFK Jr.’s Vaccine Schedule Changes Blocked — For Now
- Verily banks $300M to accelerate AI road map, transitions to independent company
- KFF: ACA plan enrollees report rising costs for 2026 coverage
- Industry Voices—Stop buying AI tools, start designing AI architecture
- CSL warns of supply shortfall, treatment delays for hemophilia gene therapy Hemgenix
- 10K Corewell Health nurses vote to authorize labor strike
- Providence mulling sale of its health plan amid financial pressures
- Fierce Pharma Asia—World's 1st brain chip nod; AZ's cell therapy bet; Astellas-CytomX breakup
- Gut Microbiome May Take Years to Recover From Antibiotic Use
- Prepared Remarks Before SEC Speaks
- The Art and Science of Materiality
- Capital, Choice, and the Pursuit of Happiness: Remarks at The SEC Speaks in 2026
- Novo's Wegovy HD passes muster under FDA national priority voucher program
- Hospital operations begin 2026 with depressed margins amid low volumes, high labor spend
- The Math Behind Eczema Flare-Ups May Finally Add Up
- Male preconception startup Upstream announces donor-matching platform
- Women's health sector could grow to $600B industry by 2030: PwC report
- Democratic senators detail plans to take on 'Big Insurance'
- Both Types Of Diabetes Increase Dementia Risk
- Aldi Recalls Spinach Bites Over Possible Contamination
- Collegium ponies up $650M to gain ADHD drug Azstarys from Corium
- Maryland bill calls for more transparency in pharma's disease awareness campaigns
- After Alfasigma's GSK licensing deal, Lynavoy picks up FDA nod in rare liver disease
- What To Know About Fatty Liver Disease and Why It’s So Common
- Drug Smoking Linked To Surge In Severe Burn Cases
- Thymus Gland Health May Be Key to Long Life and Fighting Cancer
- Premature Menopause Increases Heart Disease Risk
- U.S. Teen Obesity Hits Record Highs While Efforts to Slim Down Drop
- Pesticide Exposure Before Pregnancy Might Risk Newborn Health
- UPDATED: AstraZeneca to build cell therapy manufacturing hub, R&D center in Shanghai
- Many ACA Customers Are Paying Higher Premiums. Most Blame Trump and Republicans, Poll Finds.
- Lawmakers Seek To Protect Crisis Pregnancy Centers as Abortion Clinic Numbers Shrink
- CDMO Axplora to pump $60M into Italian complex API plant
- Pfizer eyes earlier Talzenna use after phase 3 prostate cancer win
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- Prodeon Medical FDA 510(k) approved for the Urocross Expander System, a Non-Permanent Retrievable Implant for Treating Benign Prostatic Hyperplasia
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- JenaValve Gets FDA Nod for Trilogy Transcatheter Heart Valve (THV) to Treat Aortic Regurgitation (ssAR)
- Turquoise Health raises $40M to power healthcare contracts, payments
- To tackle healthcare costs, representatives weigh curbs on provider consolidation
- A look at Highmark's specialty pharmacy partnership with Free Market Health
- AD/PD 2026: New data highlight potential cost-effectiveness of confirmatory AD blood testing in U.S. diagnostic pathways
- With downgrade, HSBC casts doubt about Lilly's 'stairway to heaven' trajectory
- TrumpRx's 'world's lowest' drug price claims fall short in global comparison: NYT
- Study Finds Little Proof Cannabis Helps Most Mental Health Conditions
- Meningitis Outbreak Tied to Students Leaves 2 Dead and 11 Sick in England
- J&J, Protagonist's 'game-changer' once-daily psoriasis pill Icotyde nabs FDA approval
- Belly Fat Linked To Heart Failure Risk
- Women More Likely To Survive Cancer Than Men — At A Cost
- BMS brings 'Emily in Paris' star and cancer survivor Ashley Park aboard campaign honoring oncologists
- Sandoz expands biosim collab with Samsung Bioepis, sets sights on Takeda's Entyvio
- Ultra-Processed Foods Linked To Heart Attack, Stroke, Cardiac Arrest
- E. Coli Outbreak Tied To Raw Cheddar Cheese Sickens 7 People
- The Sunshine Vitamin and COVID: New Study Finds Mixed Results for Recovery
- Too Much Smartphone Use Linked to Disordered Eating in Teens
- Shingles Vaccine Protects Heart Failure Patients From Heart Attack, Stroke
- White House Chief of Staff Susie Wiles Diagnosed With Early Breast Cancer
- Gates-backed TerraPower Isotopes blueprints $450M plant to supply next wave of radiopharmaceuticals
- Regulation Crypto Assets: A Token Safe Harbor
- The Last Chapter in the Book of Howey
- Payers, hospitals pan CMS' plan to bring non-network plans to ACA exchanges
- Optum Real and Suki build out collaboration to tackle payment challenges as R1 teams with AI scribe Heidi
- Indiana homes in on life sciences with $1B growth strategy, plan to create 100K jobs
- Moody's: Insurers' 2026 outlook is negative as cost pressures continue to batter industry
- GSK's management of Flovent allowed it to 'game the system': Hassan
- Allina Health to join Sutter Health in $26B proposed transaction
- Norovirus Sickens Close to 200 People on Caribbean Cruise
While Big Pharma has launched an all out campaign to oust Robert F. Kennedy, Jr. and his MAHA supporters from government, the global processed food industry has taken a much more accommodating tack:
https://www.politico.com/news/2025/09/13/maha-kennedy-trump-food-industry-washington-00561830
Publicly, this industry has been mostly quiet about MAHA. Privately, they’re panicking.
Major food companies are struggling to maintain decades-old alliances as the Make America Healthy Again movement tightens its grip on the GOP.
By Marcia Brown - September 13, 2025Some of the world’s biggest food companies are confronting a strange reality in Washington: They’re no longer getting their way.
After decades of seeing glad-handing on Capitol Hill and positive relations with the White House pay off in policy wins, food industry lobbyists are finding fewer receptive audiences and even struggling to get key meetings as consumer trends and a triumphant political movement fracture old alliances.
“Most of the food industry is like the stunned fish you get when you stick a cattle prod in a fish pond,” said one long-time food industry lobbyist granted anonymity to speak candidly.
The White House’s plan to improve children’s health, released Tuesday, is the clearest signal yet that Robert F. Kennedy Jr.’s Make America Healthy Again agenda is scrambling the equation for how K street wields its influence, leaving the food industry divided and confused.
While farm groups were able to persuade the White House to dial back its criticism of pesticides, companies that manufacture processed foods are instead seeing the Health and Human Services secretary pushing front-of-pack nutrition labeling, tighter regulations of ultra-processed foods and new limits on additives — all changes that could have significant financial implications for their trillion-dollar industry.
“These are not surprises,” said a second industry representative granted anonymity to speak candidly. “But that doesn’t mean that … this is not still a fundamental change in some things for the industry that we’re going to have to be prepared to deal with.
This account, which is based on nine interviews with representatives across the food and consumer packaged goods industry, paints a picture of a food sector at war with itself over how to respond to White House attacks — or whether to respond at all.
Tuesday’s MAHA strategy report comes as the industry is facing sweeping changes: Weight-loss drugs are shrinking serving size, states are banning ultra-processed foods from school lunches and tariffs are decimating profit margins.
Though it didn’t meaningfully change the administration’s position on food additives or labeling, some in the industry thought the MAHA strategy report represented a shift. For one, some in the industry were invited to share feedback before its publication. At the report’s launch, White House Domestic Policy Council Director Vince Haley even namechecked “recommendations from industry.” But most lobbyists are still skeptical that it’s anything more than “a bright spot,” as a third person described it.
It wouldn’t be the first time Kennedy offered an olive branch to industry without much changing his position.
He asserted during his Senate confirmation hearing in January that regulators were allowing top food brands like McDonald’s to “mass poison American children.” But two months later, he was doing a television hit at Steak ‘n Shake praising the company’s decision “RFK’ing the french fries” — swapping vegetable oil for beef tallow.
The apparent contradiction is leaving the food industry floundering. A fourth industry lobbyist said it was part of the White House’s strategy to “keep folks on their heels.”
While some parts of the food industry have won praise from administration officials for making voluntary commitments that align with White House priorities, others are struggling with their approach. Several groups and companies have shied away from publicly criticizing the administration out of fear they could become the focus of a presidential social media post, which could color consumer sentiment against their products.
In April, the American Beverage Association — a trade group representing Coca-Cola and PepsiCo among others — criticized the Trump administration for supporting a ban on food stamp recipients purchasing soda with their benefits.
Calley Means, who serves under Kennedy as a special government employee at the Department of Health and Human Services, immediately shot back: “You have lobbied millions to ensure taxpayer money funds soda for poor kids,” he posted on X.
Agriculture Secretary Brooke Rollins piled on. “It’s disappointing that the American Beverage Association’s leadership dragged its entire membership ... into direct conflict with this Administration’s priorities for American health, well-being, and taxpayer protection.”
The episode left an impression.
“There’s a keen hesitance to say anything and call a spade a spade,” said a fifth industry representative. “That’s a very different universe. Since when do big companies refrain?”
While many member companies want their trade associations to push back, the groups have largely shied away from public criticism, opting instead for voluntary commitment pledges, such as removing food dyes.
A sixth industry representative noted the surprising absence of an industry coalescing around a single mission to counter the administration.
“The rise of this sort of anti-institution sentiment and antigovernment, anti-everything has had an impact on the food industry’s ability to exert their influence,” the person added.
At the MAHA Commission’s news conference Tuesday, Rollins lauded the dairy industry for committing to cut artificial dyes from its products “even though it might hurt” companies’ bottom lines. The Trump administration is even tracking company and trade group commitments to eliminate such additives on the FDA’s website.
Groups like the Consumer Brands Association, which represents food companies like General Mills and Nestlé, are announcing voluntary programs to encourage members to eliminate artificial food dyes — over the objections of some companies. Still, other groups like the American Beverage Association are attempting to ratchet up consumer transparency by listing ingredients their members use that weren’t previously disclosed, allowed by what critics see as a loophole in the Food and Drug Administration’s regulations.
Despite these efforts, Kennedy continues to disparage their products, repeatedly saying that some of America’s most popular food items are making people sick. That rhetoric — even if it’s yet to be accompanied by serious regulatory change — has become increasingly difficult for the industry to counter. Many food lobbyists privately express similar concerns to Kennedy about chronic disease though they argue that the MAHA Commission’s proposals will do little to solve it.
And the industry recognizes that going after sugary drinks and processed food is popular across the political spectrum, making it an easy target despite company pledges to appease Kennedy on food dyes, seed oils and more.
Said a seventh lobbyist: “Is this a distraction because vaccines are so politically polarizing and there’s wins to be had here, so they’re going to come back for more?”
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
















